These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29085213)

  • 1. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
    Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
    J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
    Li O; Yi W; Yang P; Guo C; Peng C
    Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma.
    Kim HM; Park JY; Kim KS; Park MS; Kim MJ; Park YN; Bang S; Song SY; Chung JB; Park SW
    J Gastroenterol Hepatol; 2010 Feb; 25(2):286-92. PubMed ID: 19780880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.
    Ji GW; Zhu FP; Wang K; Jiao CY; Shao ZC; Li XC
    J Gastrointest Surg; 2017 Apr; 21(4):666-675. PubMed ID: 28168674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
    Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
    Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hilar cholangiocarcinoma: Value of high-resolution enhanced magnetic resonance imaging for preoperative evaluation.
    Xin Y; Liu Q; Zhang J; Lu J; Song X; Zhan H; Chen X; Cao Z; Li Y; Huang Z
    J Cancer Res Ther; 2020; 16(7):1634-1640. PubMed ID: 33565510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
    Cannon RM; Brock G; Buell JF
    HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis.
    Tang Z; Yang Y; Zhao Z; Wei K; Meng W; Li X
    Medicine (Baltimore); 2018 Aug; 97(34):e11999. PubMed ID: 30142840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Klatskin's tumors].
    Bertelsen CA; Burcharth F
    Ugeskr Laeger; 2005 Apr; 167(14):1525-30. PubMed ID: 15887750
    [No Abstract]   [Full Text] [Related]  

  • 17. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management].
    Kovalenko YA; Vishnevsky VA; Chzhao AV; Zharikov YO
    Khirurgiia (Mosk); 2018; (8):4-11. PubMed ID: 30113586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
    Ding G; Yang Y; Cao L; Chen W; Wu Z; Jiang G
    World J Surg Oncol; 2015 Mar; 13():99. PubMed ID: 25889726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
    Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
    Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.